News

PureTech Health plc announced that it has entered into a multiyear collaboration with F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc., to advance PureTech’s milk-derived exosome…
Read More...

AbbVie in cooperation with Neurocrine Biosciences announced that the U.S. Food and Drug Administration (FDA) approved ORILISSA™ (elagolix), the first and only oral…
Read More...

GSK and 23andMe unveiled an exclusive four-year collaboration that will focus on research and development of innovative new medicines and potential cures, using human genetics as the…
Read More...

Bristol-Myers Squibb Company and Tsinghua University, have entered into a collaboration to discover therapeutic agents against novel targets for autoimmune diseases and cancers. The…
Read More...

Athenex announced that both Phase 3 studies, KX-AK-003 and KX-AK-004, had achieved their primary endpoint of 100% clearance of actinic keratosis (AK) lesions at Day 57 within the face…
Read More...

STA Pharmaceutical Co., Ltd., (WuXi STA), a subsidiary of WuXi AppTec, announces that its Active Pharmaceutical Ingredient (API) manufacturing facility at Jinshan (Shanghai, China) has…
Read More...

Convelo Therapeutics, Inc. announced that it has launched from stealth mode with a mission to discover and develop a new class of medicines that regenerate the protective myelin coating…
Read More...

Pharmaceutical Product Development, LLC (PPD) has expanded its central lab technology capabilities integrated with Preclarus®, the comprehensive data solution that consolidates and…
Read More...

WuXi Biologics announced that the first GMP campaign in the new MFG3 facility was completed successfully. This 200,000 sq. ft. newly completed state-of-the-art clinical manufacturing…
Read More...

Q BioMed Inc. announced that it is extending its option agreement with Washington University in St. Louis. Under the agreement granting the exclusive right to license the technology, Q…
Read More...

MEDISCA announced the launch of SAMIX Systems, a new line of highly reliable and versatile compounding systems for efficient mixing. Through this partnership, MEDISCA will be the…
Read More...

Innovent Biologics announced that it has received Investigational New Drug (IND) approval from the China Food and Drug Administration (CFDA) to initiate clinical trials in China with…
Read More...

Pfizer announced it will increase its commitment to U.S. manufacturing with a $465 million investment to build one of the most technically advanced sterile injectable pharmaceutical…
Read More...

Allergan plc announced the U.S. Food and Drug Administration has granted Fast Track designation for AGN-241751, an investigational new treatment for Major Depressive Disorder (MDD).…
Read More...

Immunomedics announced a clinical collaboration with AstraZeneca and its global biologics research and development arm, MedImmune, to evaluate the safety and efficacy of the combination…
Read More...

Adamis Pharmaceuticals Corporation announced that it has been conducting pre-IND development work for a fast-dissolving sublingual tablet containing tadalafil. Adamis intends to submit…
Read More...

Cambrex Corporation announced it has entered into a definitive agreement to acquire Halo Pharma (Halo), a leading dosage form Contract Development and Manufacturing Organization (CDMO),…
Read More...

Koutif Therapeutics announced that KT-1002, which has been selected as its lead compound, has reached clinical candidate status for the treatment of inflammatory bowel disease,…
Read More...

Kite, a Gilead Company and Gadeta B.V., a privately-held company focused on the discovery and development of novel cancer immunotherapies based on gamma delta T cell receptors (TCRs),…
Read More...

MorphoSys AG and Galapagos NV announced that they have entered into a worldwide, exclusive agreement with Novartis Pharma AG covering the development and commercialization of their…
Read More...